Fig. 3 | Signal Transduction and Targeted Therapy

Fig. 3

From: From tuberculosis bedside to bench: UBE2B splicing as a potential biomarker and its regulatory mechanism

Fig. 3

The splicing of target three events in the TB-progression and treatment cohorts. a Bar plots of the target three splicing events in the TB-progression cohort. b The Muffz analysis showing the splicing of three events over age, exposure time, and time to TB. c Bar plots of the three splicing events in the TB-treatment cohort. d The Muffz analysis showing the splicing of the target three events over treatment duration and time to negative. PSI percent spliced in, RPS20 Ribosomal Protein S20, AP alternate promoter, KIF13B Kinesin Family Member 13B, SE skipping exon, UBE2B Ubiquitin Conjugating Enzyme E2 B, TB tuberculosis

Back to article page